BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1093059)

  • 21. [Clinical evaluation of the effectiveness of estracyt and radiation therapy in the treatment of stages II and III prostatic cancer].
    Matveev BP; Figurin KM; Minakova LR; Goikhberg MI; Aslamazov EG
    Urol Nefrol (Mosk); 1986; (2):51-4. PubMed ID: 3521041
    [No Abstract]   [Full Text] [Related]  

  • 22. Guide to the use of cancer chemotherapeutic agents.
    Bergevin PR; Tormey DC; Blom J
    Mod Treat; 1972 May; 9(2):185-273. PubMed ID: 4117324
    [No Abstract]   [Full Text] [Related]  

  • 23. The present role of estramustine phosphate in advanced prostate cancer.
    Van Poppel H; Baert L
    Prog Clin Biol Res; 1991; 370():323-41. PubMed ID: 1924466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cancer of the prostate: current status of chemotherapy].
    Bollak C; Bergerat JP; Jacquemin D
    Bull Cancer; 1986; 73(1):61-4. PubMed ID: 3535934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New agents for prostatic carcinoma.
    Mittelman A
    Urology; 1981 Apr; 17(4 Suppl):45-7. PubMed ID: 7193940
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemotherapy of malignant tumors].
    Witte S
    Internist (Berl); 1968 Sep; 9(9):365-75. PubMed ID: 4918656
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
    Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
    Schmidt JD; Scott WW; Gibbons R; Johnson DE; Prout GR; Loening S; Soloway M; deKernion JB; Pontes JE; Slack NH; Murphy GP
    Cancer; 1980 Apr; 45(7 Suppl):1937-46. PubMed ID: 6445225
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hormone therapy of male genital cancer (prostatic cancer)].
    Machida T; Ikemoto I
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2845-52. PubMed ID: 2444164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estracyt and radiotherapy in the treatment of prostatic cancer].
    Van Regemorter G; Germeau F
    Acta Urol Belg; 1980 Jan; 48(1):138-48. PubMed ID: 7435350
    [No Abstract]   [Full Text] [Related]  

  • 32. Estramustine for prostate cancer.
    Med Lett Drugs Ther; 1982 Aug; 24(615):74. PubMed ID: 7099111
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complete androgen blockade (orchiectomy + flutamide) versus androgen blockade with cytostasis (orchiectomy + estramustine) in the treatment of virginal advanced prostate cancer].
    Flamm J; Fischer M
    Wien Klin Wochenschr; 1988 Sep; 100(17):589-92. PubMed ID: 3055689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional infusion chemotherapy for cancer of the head and neck.
    Donegan WL
    Surg Annu; 1975; 7():137-73. PubMed ID: 1101400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The phase IV studies with Estracyt in prostatic cancer].
    Ohhori T; Kubo T; Akasaka T; Funyu T; Yagihashi Y; Kudo T; Tsuchida S; Harada T; Sasaki S; Orikasa S
    Hinyokika Kiyo; 1988 Aug; 34(8):1493-502. PubMed ID: 3057833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of estramustine phosphate in the treatment of patients with advanced breast cancers].
    Wada T; Morikawa E; Houjou T; Kadota K; Mori N; Matsunami N; Watatani M; Yasutomi M
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1901-4. PubMed ID: 2393306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytostatic therapy of prostatic carcinoma. Current status and personal results].
    Nagel R; Leistenschneider W
    Urologe A; 1983 Sep; 22 Suppl():304-9. PubMed ID: 6356555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I
    Orv Hetil; 1982 Jan; 123(5):287-9. PubMed ID: 7063244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.